Merck
MRK
#40
Rank
A$512.90 B
Marketcap
A$207.89
Share price
3.83%
Change (1 day)
57.92%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): A$2.04

According to Merck's latest financial reports the company's current EPS (TTM) is A$1.80. In 2025 the company made an earnings per share (EPS) of A$10.39 an increase over its 2024 EPS that were of A$9.60.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$2.04-80.33%
2025A$10.398.15%
2024A$9.604308.46%
2023A$0.22-97.32%
2022A$8.1410.92%
2021A$7.3484.68%
2020A$3.97-27.2%
2019A$5.4663.44%
2018A$3.34151.11%
2017A$1.33-54.58%
2016A$2.9330.21%
2015A$2.25-61.99%
2014A$5.92180.51%
2013A$2.11-31.82%
2012A$3.096.62%
2011A$2.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.41 590.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$9.46 426.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.08-39.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$4.43 146.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$42.46 2,261.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$23.04 1,181.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$2.70 50.37%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$6.45 258.74%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.54 152.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$0.90-50.22%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel